Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Capital Leases: 2011-2016

Historic Capital Leases for Arrowhead Pharmaceuticals (ARWR) over the last 4 years, with Jun 2016 value amounting to $378,862.

  • Arrowhead Pharmaceuticals' Capital Leases fell 36.38% to $378,862 in Q2 2016 from the same period last year, while for Jun 2016 it was $378,862, marking a year-over-year decrease of 36.38%. This contributed to the annual value of $540,792 for FY2015, which is 28.69% down from last year.
  • Arrowhead Pharmaceuticals' Capital Leases amounted to $378,862 in Q2 2016, which was down 12.03% from $430,665 recorded in Q1 2016.
  • Arrowhead Pharmaceuticals' Capital Leases' 5-year high stood at $1.4 million during Q1 2012, with a 5-year trough of $378,862 in Q2 2016.
  • For the 3-year period, Arrowhead Pharmaceuticals' Capital Leases averaged around $622,315, with its median value being $622,765 (2015).
  • Data for Arrowhead Pharmaceuticals' Capital Leases shows a maximum YoY crashed of 36.38% (in 2016) over the last 5 years.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Capital Leases (Quarterly) stood at $1.2 million in 2012, then declined by 18.03% to $1.0 million in 2013, then declined by 29.93% to $705,173 in 2014, then tumbled by 31.10% to $485,842 in 2015, then plummeted by 36.38% to $378,862 in 2016.
  • Its Capital Leases was $378,862 in Q2 2016, compared to $430,665 in Q1 2016 and $485,842 in Q4 2015.